These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12824037)

  • 1. Synthesis and biological testing of non-fluorinated analogues of levofloxacin.
    Gray JL; Almstead JI; Gallagher CP; Hu XE; Kim NK; Taylor CJ; Twinem TL; Wallace CD; Ledoussal B
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2373-5. PubMed ID: 12824037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of nitroaryl thiadiazole-levofloxacin hybrids.
    Foroumadi A; Mansouri S; Emami S; Mirzaei J; Sorkhi M; Saeid-Adeli N; Shafiee A
    Arch Pharm (Weinheim); 2006 Nov; 339(11):621-4. PubMed ID: 17036368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-hydroxy derivative as new desfluoroquinolone (DFQ): synthesis and DNA-binding study.
    Tabarrini O; Sissi C; Fravolini A; Palumbo M
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1327-36. PubMed ID: 11097062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.
    Houston AK; Jones RN
    Diagn Microbiol Infect Dis; 1994 Jan; 18(1):57-9. PubMed ID: 8026158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofloxacin, a bactericidal antibacterial.
    Smith JT
    Chemotherapy; 1991; 37 Suppl 1():2-13. PubMed ID: 1646700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
    Yamakawa T; Mitsuyama J; Hayashi K
    J Antimicrob Chemother; 2002 Mar; 49(3):455-65. PubMed ID: 11864945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of levofloxacin.
    Zhang YY; Wang F; Zhang JD; Zhu DM; Zhou L
    Drugs; 1995; 49 Suppl 2():274-5. PubMed ID: 8549330
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of differential activities of ofloxacin enantiomers.
    Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
    George J; Morrissey I
    J Antimicrob Chemother; 1997 Jun; 39(6):719-23. PubMed ID: 9222040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial activity and action mechanism of ofloxacin].
    Padeĭskaia EN
    Antibiot Khimioter; 1996; 41(9):13-23. PubMed ID: 9005780
    [No Abstract]   [Full Text] [Related]  

  • 11. The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues.
    Lawrence LE; Wu P; Fan L; Gouveia KE; Card A; Casperson M; Denbleyker K; Barrett JF
    J Antimicrob Chemother; 2001 Aug; 48(2):195-201. PubMed ID: 11481288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
    Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
    Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antibacterial activities, and pharmacological properties of enantiomers of temafloxacin hydrochloride.
    Chu DT; Nordeen CW; Hardy DJ; Swanson RN; Giardina WJ; Pernet AG; Plattner JJ
    J Med Chem; 1991 Jan; 34(1):168-74. PubMed ID: 1846917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa.
    Renau TE; Léger R; Flamme EM; She MW; Gannon CL; Mathias KM; Lomovskaya O; Chamberland S; Lee VJ; Ohta T; Nakayama K; Ishida Y
    Bioorg Med Chem Lett; 2001 Mar; 11(5):663-7. PubMed ID: 11266165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: a new class of anti-HIV agents.
    Hagihara M; Kashiwase H; Katsube T; Kimura T; Komai T; Momota K; Ohmine T; Nishigaki T; Kimura S; Shimada K
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3063-8. PubMed ID: 10560726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.
    Hoshino K; Sato K; Akahane K; Yoshida A; Hayakawa I; Sato M; Une T; Osada Y
    Antimicrob Agents Chemother; 1991 Feb; 35(2):309-12. PubMed ID: 1850968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of 1-(substituted pyrrolyl)-7-(substituted amino)-6-fluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids.
    Liu JH; Guo HY
    J Med Chem; 1992 Sep; 35(19):3469-73. PubMed ID: 1404228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of levofloxacin and ciprofloxacin against urinary pathogens.
    Drago L; De Vecchi E; Mombelli B; Nicola L; Valli M; Gismondo MR
    J Antimicrob Chemother; 2001 Jul; 48(1):37-45. PubMed ID: 11418511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fluorinated quinolones.
    Kidwai M; Misra P; Kumar R
    Curr Pharm Des; 1998 Apr; 4(2):101-18. PubMed ID: 10197035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.